Nevoid Basal Cell Carcinoma Syndrome Workup
- Author: Daniel Berg, MD, FRCP(C); Chief Editor: Dirk M Elston, MD more...
Approach Considerations
Although no routine laboratory studies are helpful for nevoid basal cell carcinoma syndrome (NBCCS), some studies may potentially aid in the diagnosis.
Molecular Genetic Testing
Molecular testing is available to confirm the diagnosis in patients with atypical findings or possibly for prenatal diagnosis. This study may be useful for infants of an affected patient who is too young to have developed diagnostic clinical findings. Because of imperfect sensitivity and specificity, genetic testing should be performed in conjunction with a genetic counselor. Availability and methodology of testing may change with time; this is another reason genetic counseling is recommended. Current and updated information on available genetic testing is available through GeneTests.
Radiography
Radiologic abnormalities, such as bifid ribs, or asymptomatic findings, such as palmar pits, may be present at a higher frequency in childhood; these findings may be helpful in making an early diagnosis.[14, 15]
Skull radiography
Calcification of the falx cerebri is the most common radiologic finding in NBCCS, occurring in 65-92% of individuals and seen on anteroposterior skull radiographs. This finding is age-related; in one study, calcification of the falx cerebri was observed in 37% of patients younger than 20 years and in 77-79% of patients older than 20 years. However, this finding may also be seen in approximately 5% of unaffected individuals.
Calcification of the tentorium cerebelli is observed in 20-40% of patients with NBCCS. This is more typically seen on lateral skull radiographs. Calcification of the petroclinoid ligament, pia, and choroid plexus may also be observed. Calcification of the diaphragma sellae may be observed in 60-80% of patients with NBCCS, as compared with 4% of the healthy population; however, some studies have suggested both a lower prevalence in the persons affected and a higher prevalence in unaffected relatives, making this finding less specific.
Therefore, consider anteroposterior and lateral radiographs of the skull or MRI if indicated to aid in diagnosis.
Skeletal radiography
Bifid, hypoplastic, fused, partially missing, or splayed ribs are observed in 38-60% of patients with NBCCS. These features may be helpful diagnostic criteria, because they are present in children before other features may show up and because they are uncommon in the general population. The most commonly affected ribs are the third, fourth and fifth ribs, although others may be involved. It is important that the radiologist specifically look for these features.
Malformations at the occipitovertebral junction and cervical or upper thoracic vertebral fusion may also be observed. In one study, calcification of the nuchal ligament occurred in 18% of affected people. Small, pseudocystic, lytic bone lesions known as "flame-shaped lucencies" are found on radiographs of the hands (30%) and feet (17%) of affected people.
Therefore, consider chest, cervical and thoracic spine (anteroposterior and lateral), and hand or foot radiographs if indicated to aid in the diagnosis. It is important to ask the radiologist to specifically look for findings of NBCCS because he or she may not otherwise comment on these.
Dental panoramic radiography
This screening is useful for the finding of odontogenic keratocysts, which are relatively common in NBCCS. When monitoring a child with NBCCS, consider regular dental visits plus panoramic radiography to detect these cysts.
Echocardiography
Cardiac fibromas have an incidence as high as 3% in some studies (rarer in other studies). In patients with NBCCS, one might consider a baseline echocardiogram at birth or within the first year of life and then subsequently, primarily if clinical suspicion arises for a cardiac fibroma.
Magnetic Resonance Imaging
Magnetic resonance imaging (MRI) may be more sensitive than plain radiography for calcification, and it may be indicated if medulloblastoma is suspected in a child with NBCCS. Because of the concern about exposure to radiation in patients with the syndrome, MRI is the preferred imaging modality over computed tomography (CT) scanning. Consider an annual MRI up to age 7 years, to coincide with the main age of risk of medulloblastoma.
Ultrasonography
To diagnose ovarian fibromas, consider performing pelvic ultrasonography around puberty, as a baseline, and later in life if symptoms are present.
Biopsy
Because the histologic features of the individual skin cancers are indistinguishable from ordinary BCC and include the full spectrum of histologic subtypes, biopsy of the skin lesions is recommended. Biopsy of jaw cysts are also recommended, as odontogenic keratocysts have a characteristic pathologic finding that shows the lining with keratinizing epithelium.
Lo Muzio L. Nevoid basal cell carcinoma syndrome (Gorlin syndrome). Orphanet J Rare Dis. Nov 25 2008;3:32. [Medline]. [Full Text].
Epstein EH. Basal cell carcinomas: attack of the hedgehog. Nat Rev Cancer. Oct 2008;8(10):743-54. [Medline].
Gorlin RJ. 2004 ASHG Award for Excellence in Human Genetics Education. And the band played on... Am J Hum Genet. Feb 2005;76(2):216-8. [Medline]. [Full Text].
Gorlin RJ. Nevoid basal cell carcinoma (Gorlin) syndrome. Genet Med. Nov-Dec 2004;6(6):530-9. [Medline].
Hahn H, Wicking C, Zaphiropoulous PG, Gailani MR, Shanley S, Chidambaram A, et al. Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome. Cell. Jun 14 1996;85(6):841-51. [Medline].
High A, Zedan W. Basal cell nevus syndrome. Curr Opin Oncol. Mar 2005;17(2):160-6. [Medline].
Johnson RL, Rothman AL, Xie J, Goodrich LV, Bare JW, Bonifas JM, et al. Human homolog of patched, a candidate gene for the basal cell nevus syndrome. Science. Jun 14 1996;272(5268):1668-71. [Medline].
Goldstein AM, Bale SJ, Peck GL, DiGiovanna JJ. Sun exposure and basal cell carcinomas in the nevoid basal cell carcinoma syndrome. J Am Acad Dermatol. Jul 1993;29(1):34-41. [Medline].
Evans DG, Farndon PA, Burnell LD, Gattamaneni HR, Birch JM. The incidence of Gorlin syndrome in 173 consecutive cases of medulloblastoma. Br J Cancer. Nov 1991;64(5):959-61. [Medline]. [Full Text].
Evans DG, Ladusans EJ, Rimmer S, Burnell LD, Thakker N, Farndon PA. Complications of the naevoid basal cell carcinoma syndrome: results of a population based study. J Med Genet. Jun 1993;30(6):460-4. [Medline]. [Full Text].
Gorlin RJ. Nevoid basal-cell carcinoma syndrome. Medicine (Baltimore). Mar 1987;66(2):98-113. [Medline].
Shanley S, Ratcliffe J, Hockey A, Haan E, Oley C, Ravine D, et al. Nevoid basal cell carcinoma syndrome: review of 118 affected individuals. Am J Med Genet. Apr 15 1994;50(3):282-90. [Medline].
Kimonis VE, Goldstein AM, Pastakia B, Yang ML, Kase R, DiGiovanna JJ, et al. Clinical manifestations in 105 persons with nevoid basal cell carcinoma syndrome. Am J Med Genet. Mar 31 1997;69(3):299-308. [Medline].
Veenstra-Knol HE, Scheewe JH, van der Vlist GJ, van Doorn ME, Ausems MG. Early recognition of basal cell naevus syndrome. Eur J Pediatr. Mar 2005;164(3):126-30. [Medline].
Kimonis VE, Mehta SG, Digiovanna JJ, Bale SJ, Pastakia B. Radiological features in 82 patients with nevoid basal cell carcinoma (NBCC or Gorlin) syndrome. Genet Med. Nov-Dec 2004;6(6):495-502. [Medline].
Ferreres JR, Macaya A, Jucglà A, Muniesa C, Prats C, Peyrí J. Hundreds of basal cell carcinomas in a Gorlin-Goltz syndrome patient cured with imiquimod 5% cream. J Eur Acad Dermatol Venereol. Aug 2006;20(7):877-8. [Medline].
Itkin A, Gilchrest BA. delta-Aminolevulinic acid and blue light photodynamic therapy for treatment of multiple basal cell carcinomas in two patients with nevoid basal cell carcinoma syndrome. Dermatol Surg. Jul 2004;30(7):1054-61. [Medline].
Oseroff AR, Shieh S, Frawley NP, Cheney R, Blumenson LE, Pivnick EK, et al. Treatment of diffuse basal cell carcinomas and basaloid follicular hamartomas in nevoid basal cell carcinoma syndrome by wide-area 5-aminolevulinic acid photodynamic therapy. Arch Dermatol. Jan 2005;141(1):60-7. [Medline].
Skvara H, Kalthoff F, Meingassner JG, et al. Topical treatment of Basal cell carcinomas in nevoid Basal cell carcinoma syndrome with a smoothened inhibitor. J Invest Dermatol. Aug 2011;131(8):1735-44. [Medline].

